Arkolith/Insider Trading/COEP/Form 4

Salkind Gene

DirectorCoeptis Therapeutics Holdings, Inc. (COEP) · full profile →Form 4 · filed Aug 30, 2023
Net Buying
Open-Market Buys
$30K
Open-Market Sells
$0
Net Open-Market Flow
$30K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 29, 2023Buy(P)4K$1.01$4K4K
Aug 25, 2023Buy(P)29K$0.91$26K29K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683168-23-006169) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML